Depot formulations to sustain periocular drug delivery to the posterior eye segment

被引:31
|
作者
Agban, Yosra [1 ]
Thakur, Sachin S. [1 ]
Mugisho, Odunayo O. [1 ]
Rupenthal, Ilva D. [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, New Zealand Natl Eye Ctr, Dept Ophthalmol,Buchanan Ocular Therapeut Unit, Private Bag 92019, Auckland 1142, New Zealand
关键词
BIODEGRADABLE INTRASCLERAL IMPLANT; INTRAVITREAL CONTROLLED-RELEASE; RETINAL-PIGMENT EPITHELIUM; TRANSSCLERAL DELIVERY; TRIAMCINOLONE ACETONIDE; HUMAN SCLERA; SUBCONJUNCTIVAL INJECTION; ANECORTAVE ACETATE; POLYMERIC DEVICE; NANO-PARTICLES;
D O I
10.1016/j.drudis.2019.03.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The periocular space is a promising alternative route for the delivery of drugs to the posterior eye segment, especially when treating conditions in the outer ocular layers. In this review, we discuss the different periocular routes as well as the physiological barriers and elimination mechanisms limiting drug bioavailability at the back of the eye. We then highlight various types of depot formulations, including particulate delivery systems, semisolid formulations, and implants, used to increase the contact time with the ocular tissues. With the additional advantage of sustaining drug release, such depot formulations could enhance periocular drug delivery to the posterior eye segment.
引用
收藏
页码:1458 / 1469
页数:12
相关论文
共 50 条
  • [1] Barrier analysis of periocular drug delivery to the posterior segment
    Ranta, Veli-Pekka
    Mannermaa, Eliisa
    Lummepuro, Kirsi
    Subrizi, Astrid
    Laukkanen, Antti
    Antopolsky, Maxim
    Murtomaki, Lasse
    Hornof, Margit
    Urtti, Arto
    [J]. JOURNAL OF CONTROLLED RELEASE, 2010, 148 (01) : 42 - 48
  • [2] Drug delivery to the posterior segment of the eye
    Thrimawithana, Thilini Rasika
    Young, Simon
    Bunt, Craig Robert
    Green, Colin
    Alany, Raid Ghassan
    [J]. DRUG DISCOVERY TODAY, 2011, 16 (5-6) : 270 - 277
  • [3] Drug delivery to the posterior segment of the eye
    Fischer, Naomi
    Narayanan, Raja
    Loewenstein, Anat
    Kuppermann, Baruch D.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 : S20 - S26
  • [4] Systems for drug delivery to the posterior segment of the eye
    Weiner, Alan L.
    Marsh, David A.
    [J]. RETINAL AND CHOROIDAL ANGIOGENESIS, 2008, : 419 - 444
  • [5] Drug delivery for posterior segment eye disease
    Geroski, DH
    Edelhauser, HF
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (05) : 961 - 964
  • [6] Drug delivery to target the posterior segment of the eye
    Behar-Cohen, F
    [J]. M S-MEDECINE SCIENCES, 2004, 20 (6-7): : 701 - 706
  • [7] Topical Drug Delivery to the Posterior Segment of the Eye
    Loescher, Marina
    Seiz, Chiara
    Hurst, Jose
    Schnichels, Sven
    [J]. PHARMACEUTICS, 2022, 14 (01)
  • [8] Polymeric nanoparticles for drug delivery to the posterior segment of the eye
    Bejjani, RA
    Behar-Cohen, F
    Benezra, D
    Gurny, R
    Delie, F
    [J]. CHIMIA, 2005, 59 (06) : 344 - 347
  • [9] New Techniques for Drug Delivery to the Posterior Eye Segment
    Eljarrat-Binstock, Esther
    Pe'er, Jacob
    Domb, Abraham J.
    [J]. PHARMACEUTICAL RESEARCH, 2010, 27 (04) : 530 - 543
  • [10] New Techniques for Drug Delivery to the Posterior Eye Segment
    Esther Eljarrat-Binstock
    Jacob Pe’er
    Abraham J. Domb
    [J]. Pharmaceutical Research, 2010, 27 : 530 - 543